Compare FCEL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCEL | CTKB |
|---|---|---|
| Founded | 1969 | 1990 |
| Country | United States | United States |
| Employees | 629 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 592.3M | 595.2M |
| IPO Year | N/A | 2021 |
| Metric | FCEL | CTKB |
|---|---|---|
| Price | $13.57 | $4.91 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.31 | $5.63 |
| AVG Volume (30 Days) | ★ 5.8M | 516.9K |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $4.77 | $5.42 |
| Revenue Next Year | $42.46 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $3.66 | $2.37 |
| 52 Week High | $14.30 | $6.18 |
| Indicator | FCEL | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 70.52 | 62.79 |
| Support Level | $6.90 | $4.13 |
| Resistance Level | N/A | $5.24 |
| Average True Range (ATR) | 1.41 | 0.21 |
| MACD | 0.40 | 0.02 |
| Stochastic Oscillator | 90.06 | 90.23 |
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.